Tokiyoshi Tanegashima, Masaki Shiota, Nobuhiro Fujiyama, Shintaro Narita, Tomonori Habuchi, Genshiro Fukuchi, Dai Takamatsu, Yoshinao Oda, Hideaki Miyake, Masayuki Takahashi, et al. Effect of HLA Genotype on Anti-PD-1 Antibody Treatment for Advanced Renal Cell Carcinoma in the SNiP-RCC Study. Journal of immunology (Baltimore, Md. : 1950). 2024. 213. 1. 23-28
Nobuhiro Fujiyama, Masayuki Tasaki, Hiroshi Harada, Koichi Tsutahara, Akihiko Matsumoto, Yuji Kamijo, Mariko Toyoda, Daiki Iwami, Masashi Inui, Hiroki Shirakawa, et al. Immunological risk and complement genetic evaluations in early onset de novo thrombotic microangiopathy after living donor kidney transplantation: a Japanese multicenter registry. Clinical and experimental nephrology. 2023
Hiroshi Harada, Nobuyuki Fukuzawa, Toyofumi Abe, Ryoichi Imamura, Noriyuki Masaki, Nobuhiro Fujiyama, Shigeru Sato, Shingo Hatakeyama, Kenji Nishimura, Hidefumi Kishikawa, et al. Development and nationwide validation of kidney graft injury markers using urinary exosomes and microvesicles (complete English translation of the Japanese version). BMC Nephrology. 2023. 24. 1
Shuhei Takahashi, Shintaro Narita, Nobuhiro Fujiyama, Shingo Hatakeyama, Takashi Kobayashi, Renpei Kato, Sei Naito, Toru Sakatani, Soki Kashima, Atsushi Koizumi, et al. Impact of germline HLA genotypes on clinical outcomes in patients with urothelial cancer treated with pembrolizumab. Cancer science. 2022. 113. 12. 4059-4069
Mizuki Kobayashi, Nobuhiro Fujiyama, Tokiyoshi Tanegashima, Shintaro Narita, Yoshiaki Yamamoto, Naohiro Fujimoto, Shohei Ueda, Ario Takeuchi, Kazuyuki Numakura, Tomonori Habuchi, et al. Effect of HLA genotype on intravesical recurrence after bacillus Calmette-Guérin therapy for non-muscle-invasive bladder cancer. Cancer immunology, immunotherapy : CII. 2022. 71. 3. 727-736
Yu Ho Lee, Yuki Sato, Mitsuru Saito, Shingo Fukuma, Atsushi Komatsuda, Nobuhiro Fujiyama, Shigeru Satoh, Tomonori Habuchi, Sang-Ho Lee, Peter Peter, et al. ADVANCED TERTIARY LYMPHOID TISSUES IN PROTOCOL BIOPSIES PREDICT PROGRESSIVE GRAFT DYSFUNCTION IN KIDNEY TRANSPLANT RECIPIENTS. TRANSPLANTATION. 2020. 104. 9. S39-S39
Ryoma Igarashi, Norihiko Tsuchiya, Takamitsu Inoue, Nobuhiro Fujiyama, Kazuyuki Numakura, Hiroshi Tsuruta, Hideaki Kagaya, Atsushi Maeno, Mitsuru Saito, Shintaro Narita, et al. CONTRIBUTION OF GENETIC POLYMORPHISMS RELATED TO AXITINIB PHARMACOKINETICS TO THE CLINICAL SAFETY AND EFFICACY IN PATIENTS WITH ADVANCED RENAL CELL CARCINOMA. JOURNAL OF UROLOGY. 2017. 197. 4. E182-E182
Norihiko Tsuchiya, Nobuhiro Fujiyama, Ryoma Igarashi, Naoko Honma, Shintaro Narita, Takamitsu Inoue, Kazuyuki Numakura, Susumu Akihama, Mitsuru Saito, Shigeru Satoh, et al. ASSOCIATION BETWEEN PLASMA CONCENTRATION OF AXITINIB AND TREATMENT OUTCOME IN ADVANCED RENAL CELL CARCINOMA PATIENTS. JOURNAL OF UROLOGY. 2015. 193. 4. E872-E873
Norihiko Tsuchiya, Ryoma Igarashi, Naoko Suzuki-Honma, Nobuhiro Fujiyama, Shintaro Narita, Takamitsu Inoue, Mitsuru Saito, Susumu Akihama, Hiroshi Tsuruta, Masatomo Miura, et al. Association of pharmacokinetics of axitinib with treatment outcome and adverse events in advanced renal cell carcinoma patients. JOURNAL OF CLINICAL ONCOLOGY. 2015. 33. 7